NitroMist NovaDel Pharma - Treatment for Angina Pectoris
NitroMist is an oral spray formulation of nitroglycerin indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.
Related articles
- FDA Accepts Submission for NitroMist as Complete Response - May 26, 2006
- NovaDel Pharma Receives Approvable Letter from the FDA for NitroMist - nitroglycerin lingual aerosol - June 2, 2005
- NovaDel NDA for Nitroglycerin Lingual Spray is Accepted for Review by FDA - September 29, 2004
- NovaDel Pharma files for US FDA approval of Nitroglycerin Lingual Spray, its first product - June 21, 2004
NitroMist (nitroglycerin) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.